# Aptevo Therapeutics Inc.: Form 8-K, filed Jun 20, 2025

- Company: [Aptevo Therapeutics Inc.](/companies/apvo.md) (CIK 1671584)
- Form: 8-K
- Filed: 2025-06-20
- Accepted by EDGAR: Jun 20, 2025, 17:21 ET
- Period: 2025-06-20
- Accession: 0000950170-25-088592
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1671584/000095017025088592/apvo-20250620.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1671584/000095017025088592/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1671584/000095017025088592/apvo-20250620.htm

Filed Jun 20, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-088592. Last ingested by Listed: Oct 30, 2026, 16:45 ET. No prices; not investment advice.